Skip to search.
 TSX Up1.03% TSX Ventures 0.00%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS

7.99 Up 0.03(0.38%) 4:00PM EDT|After Hours : 7.98 Down 0.01 (0.13%) 6:04PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2012-12-302011-12-302010-12-30
Total Revenue 27,587   12,719   16,613  
Cost of Revenue3,671  8,100  7,414  
Gross Profit 23,916   4,619   9,199  
Operating Expenses
Research Development54,112  58,706  75,459  
Selling General and Administrative26,226  24,248  27,936  
Non Recurring -  3,467   -  
Others691  997  2,159  
Total Operating Expenses -  87,418   -  
Operating Income or Loss (57,113) (82,799) (96,355)
Income from Continuing Operations
Total Other Income/Expenses Net(19,244)(12,116)(6,498)
Earnings Before Interest And Taxes(76,357)(94,915)(102,853)
Interest Expense9,120  14,309  21,681  
Income Before Tax(85,477)(109,224)(124,534)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(91,815)(119,738)(136,888)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (85,477) (109,224) (124,534)
Preferred Stock And Other Adjustments(2,824)(2,260) -  
Net Income Applicable To Common Shares (88,301) (111,484) (124,534)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.